in Nanyang. Shelley German pharmaceutical company joins forces with China Biopharmaceuticals to collaborate on new cancer drugs with a potential value exceeding 28 billion.
The German pharmaceutical company Boehringer Ingelheim signed a licensing agreement with Sino Biopharmaceuticals and its partners.